Skip to main content

Table 6 Clinical baseline of UCEC patients for DFS obtained from TCGA database

From: Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma

Variables

UCEC

N = 450(%)

Age

63(56.8,70)

Stage

 

 Stage I–II

328(72.9%)

 Stage III–IV

122(27.1%)

Grade

 

 G1–2

195(43.3%)

 G3–4

255(56.7%)

Histologic type

 

 Endometrioid

339(75.3%)

 Mixed & serous

111(24.7%)

Risk

 

 Low

224(49.8%)

 High

226(50.2%)